Key Findings

The majority of net healthcare spending is on hospital and medical services, while PBS net spending has declined from 8% to 5% since 2010.

Historical Percentage of Overall Net Healthcare Spending by Sector, Fiscal Years 2010–2018, AU$Bn

• Australia’s net healthcare spending has increased from $121.5 billion to $183.1 billion in fiscal year from 2010 to 2018.
• 医院和医疗服务是净医疗保健支出中最大的比例，在截至2018财政年度的成本为1,240亿美元，而PBS净制药支出的成本已从净医疗保健支出的8％lol买外围用什么软件下降到5％。
• All other medicines spending has remained a constant share of net healthcare spending at 6%.

在过去的10年中，药品的总未填补收入增加了，但在考虑回扣时仍然保持平坦。

2010 - 2019年财政年度的全部未订立收入，折扣和报告的净支出，澳元

• Over the last 10 years, total non-discounted revenue from pharmaceuticals has increased 25.9%, reaching just over $12.0 billion in fiscal year 2019.
• However, net revenues have remained relatively constant over the ten-year period after accounting for rebates, which have risen from $9.3 billion to $9.8 billion — a 5% increase since fiscal year 2010.

Pharmaceutical spending growth is largely flat after accounting for rebates, and is driven by protected brand volume and new brands, offset by price events.

品牌量，新品牌和净价格贡献增长，2010- 2019财年，澳元

• 价格事件是该期间最大的负面增长驱动力，在截至2017年的财政年度中，高峰期为22.74亿美元。这相当于五年内的复合年增长率为-22.3％，在9级中为-17.3％年期。
• Protected brand volume remains a strong positive contributor to growth especially in 2016 and 2017.
• As a result of the negative contribution of price events in fiscal years ending 2013, 2014, 2015 and 2017, total pharmaceutical spending growth declined despite the positive contribution of growth by new brands.

Net pharmaceutical revenues and PBS spending have remained constant on an adjusted per capita basis averaging slightly over $1 per day.

Historical Real Net Per Capita PBS Spending, Revenues, and GDP, Fiscal Years 2010–2018, AU$ 2019$

• 根据调整后的人均基础，澳大利亚人每天支付的费用超过1美元，以获取PBS药物。
• Spending on PBS medicines was $390 in 2019, which was up 6% from a low of $366 in 2010.
• 人均净PBS支出和人均净药品收入分别分别占2018财年人均GDP的0.7％，从2010财年下降了0.9％。